It is a pharma private limited company based in Hubli, Karnataka, India, established in 2018.
2018 | Hubli, Karnataka, India | ActiveCuremark Medi Sciences Private Limited, a active private limited company, was established on 12 March 2018 in Hubli, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74999KA2018PTC111014. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Pradeep Hodaghatta Puttaraju (Director), Umesh Naganagoud Hotagigoudr (Managing Director), Pallavi Umesh Hotagigouder (Director). It holds ₹0.99 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Cts No. 4911/28, # 1, Aroodha Neralu, Gr Floor, Lothimath Layout, Heggeri Road, Old Hubl, I,, Hubli, Karnataka, 580024.
U74999KA2018PTC111014
111014
12 March 2018
₹1.00 M
₹0.10 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Curemark Medi Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pradeep Hodaghatta Puttaraju | Director | 01 Oct 2020 | Current |
| Umesh Naganagoud Hotagigoudr | Managing Director | 12 Mar 2018 | Current |
| Pallavi Umesh Hotagigouder | Director | 12 Mar 2018 | Current |
| Sukesha Manjupoojari | Director | 12 Mar 2018 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Curemark Medi Sciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.73% increase. The company also saw a substantial fall in profitability, with a 125.44% decrease in profit. The company's net worth observed a substantial decline by a decrease of 198.57%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Curemark Medi Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹990,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Aug 2020 | Others | ₹0.99 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Curemark Medi Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Curemark Medi Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curemark Medi Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Curemark Medi Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Curemark Medi Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
Pradeep Hodaghatta Puttaraju was appointed as a Director was appointed as a Director on 01 Oct 2020 & has been associated with this company since 5 years 2 months . was recorded as a recent event.
The activity A charge with Others amounted to Rs. 0.99 M with Charge ID 100360494 was registered on 11 Aug 2020. was completed.
Progress on Umesh Naganagoud Hotagigoudr was appointed as a Managing Director was appointed as a Managing Director on 12 Mar 2018 & has been associated with this company since 7 years 9 months . was documented.
The activity Pallavi Umesh Hotagigouder was appointed as a Director was appointed as a Director on 12 Mar 2018 & has been associated with this company since 7 years 9 months . was completed.
The CIN of Curemark Medi Sciences Private Limited is U74999KA2018PTC111014.
Curemark Medi Sciences Private Limited is headquartered at Cts No. 4911/28, # 1, Aroodha Neralu, Gr Floor, Lothimath Layout, Heggeri Road, Old Hubl, I,, Hubli, Karnataka, 580024.
Curemark Medi Sciences Private Limited was incorporated on 12 March 2018.
The current directors of Curemark Medi Sciences Private Limited are
The primary industry of Curemark Medi Sciences Private Limited is Manufacturing.
Curemark Medi Sciences Private Limited is unlisted.
The authorized capital of Curemark Medi Sciences Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX